CH1/Clambda Fab based on Pertuzumab
Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| H [auth L] | Rogdi_lz | e5vshL1 | A: a/b three-layered sandwiches | X: Flavodoxin-like | H: Class I glutamine amidotransferase-like | T: Chelatase-like | F: Rogdi_lz | ECOD (v294.1) |
| F | Rogdi_lz | e5vshF1 | A: a/b three-layered sandwiches | X: Flavodoxin-like | H: Class I glutamine amidotransferase-like | T: Chelatase-like | F: Rogdi_lz | ECOD (v294.1) |
| D | Rogdi_lz | e5vshD1 | A: a/b three-layered sandwiches | X: Flavodoxin-like | H: Class I glutamine amidotransferase-like | T: Chelatase-like | F: Rogdi_lz | ECOD (v294.1) |
| B | Rogdi_lz | e5vshB1 | A: a/b three-layered sandwiches | X: Flavodoxin-like | H: Class I glutamine amidotransferase-like | T: Chelatase-like | F: Rogdi_lz | ECOD (v294.1) |
| G [auth H] | Rogdi_lz | e5vshH1 | A: a/b three-layered sandwiches | X: Flavodoxin-like | H: Class I glutamine amidotransferase-like | T: Chelatase-like | F: Rogdi_lz | ECOD (v294.1) |
| E | Rogdi_lz | e5vshE1 | A: a/b three-layered sandwiches | X: Flavodoxin-like | H: Class I glutamine amidotransferase-like | T: Chelatase-like | F: Rogdi_lz | ECOD (v294.1) |
| C | Rogdi_lz | e5vshC1 | A: a/b three-layered sandwiches | X: Flavodoxin-like | H: Class I glutamine amidotransferase-like | T: Chelatase-like | F: Rogdi_lz | ECOD (v294.1) |
| A | Rogdi_lz | e5vshA1 | A: a/b three-layered sandwiches | X: Flavodoxin-like | H: Class I glutamine amidotransferase-like | T: Chelatase-like | F: Rogdi_lz | ECOD (v294.1) |
Domain Annotation: CATH CATH Database Homepage
| Chain | Domain | Class | Architecture | Topology | Homology | Provenance Source (Version) |
|---|---|---|---|---|---|---|
| H [auth L] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| F | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| D | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| B | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| G [auth H] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| E | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| C | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| A | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
IMGT Antibody Annotation IMGT Database Homepage
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|---|---|---|---|---|---|---|---|
| B, D, F, H [auth L] | Fab Pertuzumab | L-KAPPA | Homo sapiens (human) | IGKV1D-7-1*01, IGKJ1*01, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202612-0) |
| A, C, E, G [auth H] | Fab Pertuzumab | VH-CH1 | Homo sapiens (human) | IGHV3-23*04, IGHJ2*01, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGHG1*01, IGHG1*02, IGHG1*04, IGHG1*05, IGHG1*12, IGHG1*14, IGHG1*13, IGHG1*09, IGHG1*10, IGHG1*07, IGHG1*11, IGHG1*15, IGHG1*16 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202612-0) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| B, D, F, H [auth L] | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-03-27) |
| A, C, E, G [auth H] | Heavy Chain | IGHV3 | - | - | SAbDab (2026-03-27) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| B, D, F, H [auth L] | Zanidatamab | ERBB2/CD340/HER2 | Therapeutic SAbDab (2026-03-27) |
| A, C, E, G [auth H] | Zanidatamab | ERBB2/CD340/HER2 | Therapeutic SAbDab (2026-03-27) |














